The company holds the global rights to the name and trademark “Merck” internationally. In 2022, Merck KGaA, Darmstadt, Germany, generated sales of € 22.2 billion in 66 countries. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. The company has a total of three Centers of Excellence for dry powder cell culture media manufacturing: in addition to the site in Lenexa, Kansas, serving the Americas region, and Nantong, China, for the Asia Pacific region, the third site is located in Irvine, Scotland, serving Europe, the Middle East and Africa region.Ībout the Life Science business of Merck KGaA, Darmstadt, Germany “The new production line is the culmination of multiple years of planning, and now we are able to offer greater flexibility and faster cell culture media manufacturing for our customers.” The new production line represents the company’s vision for our Lenexa site, as it was initially constructed for three manufacturing lines for dry powder cell culture media,” says Darren. “As our customers’ needs and technologies evolve, so must we. The company’s strategic investments to expand capacity with the new dry powder media manufacturing lines in existing production facilities in the Lenexa, Kansas, and Nantong, China, sites will increase both local and global production capacity to meet current demand and ensure robust supply for future demand surges. “These new opportunities at MilliporeSigma will allow even more families throughout the region to prosper.” “Governor Kelly’s administration knows that supporting private sector efforts to strengthen supply chains benefits Kansas workers,” said David Toland, Kansas Lieutenant Governor and Secretary of Commerce. Because of its central role in biomanufacturing, a consistent supply of high-quality media is required to deliver the necessary concentration and protein quality for therapeutics. Investing in the region reflects our strategy to expand and diversify our supply chain to ensure we meet current and future demand for cell culture media.”Ĭell culture media is an essential raw material used in the manufacture of life-saving therapies and in processes as varied as vaccine manufacturing, gene therapy, and monoclonal antibody manufacturing. “This expansion makes Lenexa the company’s largest dry powder cell culture media facility and Center of Excellence in North America. “The Lenexa expansion reflects our commitment to meeting the dynamic needs of our customers worldwide and delivering on our growth plans,” said Darren Verlenden, Head of Process Solutions, Life Science. and Canada Life Science business of Merck KGaA, Darmstadt Germany, today announced the expansion of its facility in Lenexa, Kansas, adding 98,000 square feet of lab space and production capability to manufacture cell culture media. Cell culture media is an essential raw material used in the manufacture of life-saving therapies and in processes as varied as vaccine manufacturing, gene therapy, and monoclonal antibody manufacturing.īurlington, MA, J– MilliporeSigma, the U.S. MilliporeSigma, the Life Science business of Merck KGaA Darmstadt Germany, is investing $25 Million into its Lenexa, Kansas, facility, to support the manufacturing of dry powder cell culture media.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |